Mohamed M. M. AbdelRazek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohamed M. M. AbdelRazek has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Ashaimaa Yehia Moussa
Department of Pharmacognosy, Faculty of Pharmacy Ain Shams University Cairo Egypt
4 shared publications Abdel Nasser B. Singab
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, 11566-Abbassia, Cairo, Egypt
2 shared publications- Abdel Nasser B. Singab
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
2 shared publications - Ahmed M. Elissawy
Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt
2 shared publications Asmaa M. Atta
2 shared publications- Nada M. Mostafa
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
2 shared publications
Latest Publications
- 26 June 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (7) , 2697-2721
Reassessing ADHD Management: Integrating Gut Microbiome Insights and Herbal Nutritional Strategies
- 26 June 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (7) , 2697-2721
Reassessing ADHD Management: Integrating Gut Microbiome Insights and Herbal Nutritional Strategies
- Open Access
- 16 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Comparative chemical and biological study of essential oils and n-hexane extracts of Thymus vulgaris and Thymus serpyllum (Lamiaceae)
This study presents a comparative chemical and biological evaluation of essential oils (EOs) and n -hexane extracts from Thymus vulgaris and Thymus serpyllum (Lamiaceae), alongside a reference commercial thyme oil. GC-MS analysis revealed significant differences in chemical composition among the samples, with T. serpyllum oil characterized by high thymol (74.47%) and caryophyllene (9.89%) content, while the commercial oil was dominated by carvacrol (80.37%). Cytotoxicity was assessed using the sulforhodamine B (SRB) assay on human skin fibroblast (HSF) cells to evaluate safety. Most samples exhibited low cytotoxicity (IC 50 > 100 µg/mL), except for T. serpyllum oil, which showed strong cytotoxicity (IC 50 = 18.48 µg/mL). Antidiabetic activity was evaluated via α-glucosidase and α-amylase inhibition assays. T. serpyllum oil demonstrated moderate α-glucosidase inhibition (IC 50 = 536.9 ± 1.04 µg/mL), while other samples showed weak or negligible activity. Wound healing potential was assessed using an in vitro scratch assay on HSF cells. T. serpyllum oil at 0.05 µg/mL achieved complete wound closure within 72 h, outperforming other samples, including the commercial reference. Molecular docking of its major compounds (thymol, caryophyllene, α-selinene, and 3’,5’-dimethoxyacetophenone) revealed favorable binding affinities to key wound healing targets (collagenase, MMP-12, TGF-β), supporting the observed biological activity. Overall, T. serpyllum EO (TSV) exhibited superior wound healing capacity and moderate antidiabetic activity, with acceptable safety at low concentrations. These findings highlight its potential as a natural therapeutic agent and underscore the importance of standardizing thyme products for consistent pharmacological efficacy.
- 16 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessComparative chemical and biological study of essential oils and n-hexane extracts of Thymus vulgaris and Thymus serpyllum (Lamiaceae)
This study presents a comparative chemical and biological evaluation of essential oils (EOs) and n -hexane extracts from Thymus vulgaris and Thymus serpyllum (Lamiaceae), alongside a reference commercial thyme oil. GC-MS analysis revealed significant differences in chemical composition among the samples, with T. serpyllum oil characterized by high thymol (74.47%) and caryophyllene (9.89%) content, while the commercial oil was dominated by carvacrol (80.37%). Cytotoxicity was assessed using the sulforhodamine B (SRB) assay on human skin fibroblast (HSF) cells to evaluate safety. Most samples exhibited low cytotoxicity (IC 50 > 100 µg/mL), except for T. serpyllum oil, which showed strong cytotoxicity (IC 50 = 18.48 µg/mL). Antidiabetic activity was evaluated via α-glucosidase and α-amylase inhibition assays. T. serpyllum oil demonstrated moderate α-glucosidase inhibition (IC 50 = 536.9 ± 1.04 µg/mL), while other samples showed weak or negligible activity. Wound healing potential was assessed using an in vitro scratch assay on HSF cells. T. serpyllum oil at 0.05 µg/mL achieved complete wound closure within 72 h, outperforming other samples, including the commercial reference. Molecular docking of its major compounds (thymol, caryophyllene, α-selinene, and 3’,5’-dimethoxyacetophenone) revealed favorable binding affinities to key wound healing targets (collagenase, MMP-12, TGF-β), supporting the observed biological activity. Overall, T. serpyllum EO (TSV) exhibited superior wound healing capacity and moderate antidiabetic activity, with acceptable safety at low concentrations. These findings highlight its potential as a natural therapeutic agent and underscore the importance of standardizing thyme products for consistent pharmacological efficacy.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
From wastes to therapeutic treasure: phytochemistry, molecular docking, and DFT-based reactivity profiling of walnut green husk and shell
The walnut by-products can be valuable sources of biologically active compounds for future food, pharmaceutical, and other biotechnological applications.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessFrom wastes to therapeutic treasure: phytochemistry, molecular docking, and DFT-based reactivity profiling of walnut green husk and shell
The walnut by-products can be valuable sources of biologically active compounds for future food, pharmaceutical, and other biotechnological applications.
- Open Access
- 11 November 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (49) , 36451-36460
Bioactive secondary metabolites from fungal endophytes, Penicillium oxalicum and Phoma herbarum , associated with Morus nigra and Ficus sycomorus : an in silico study
Two pure fungal strains were isolated and identified from Ficus sycomorus and Morus nigra , namely, Penicillium oxalicum (OR673586) and Phoma herbarum (OR673589), respectively.
- 11 November 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (49) , 36451-36460
Open AccessBioactive secondary metabolites from fungal endophytes, Penicillium oxalicum and Phoma herbarum , associated with Morus nigra and Ficus sycomorus : an in silico study
Two pure fungal strains were isolated and identified from Ficus sycomorus and Morus nigra , namely, Penicillium oxalicum (OR673586) and Phoma herbarum (OR673589), respectively.
- Open Access
- 26 April 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (18) , 20477-20487
LC-ESI-MS/MS-Based Comparative Metabolomic Study, Antioxidant and Antidiabetic Activities of Three Lobelia Species: Molecular Modeling and ADMET Study
The hydroethanol (70%) extracts of three Lobelia species (L. nicotianifolia, L. sessilifolia, and L. chinensis) were analyzed using LC-ESI-MS/MS. Forty-five metabolites were identified, including different flavonoids, coumarin, polyacetylenes, and alkaloids, which were the most abundant class. By applying Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) based on LC-ESI-MS/MS analysis, the three species were completely segregated from each other. In addition, the three Lobelia extracts were tested for their antioxidant activities using a DPPH assay and as antidiabetic agents against α-glycosidase and α-amylase enzymes. L. chinensis extract demonstrated significant antioxidant activity with an IC50 value of 1.111 mg/mL, while L. nicotianifolia showed mild suppressing activity on the α-glycosidase activity with an IC50 value of 270.8 μg/mL. A molecular simulation study was performed on the main compounds to predict their potential antidiabetic activity and pharmacokinetic properties. The molecular docking results confirmed the α-glycosidase inhibitory activity of the tested compounds, as seen in their binding mode to the key amino acid residues at the binding site compared to that of the standard drug acarbose. Furthermore, the predictive ADMET results revealed good pharmacokinetic properties of almost all of the tested compounds. The biological evaluation results demonstrated the promising activity of the tested compounds, aligned with the in silico results.
- 26 April 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (18) , 20477-20487
Open AccessLC-ESI-MS/MS-Based Comparative Metabolomic Study, Antioxidant and Antidiabetic Activities of Three Lobelia Species: Molecular Modeling and ADMET Study
The hydroethanol (70%) extracts of three Lobelia species (L. nicotianifolia, L. sessilifolia, and L. chinensis) were analyzed using LC-ESI-MS/MS. Forty-five metabolites were identified, including different flavonoids, coumarin, polyacetylenes, and alkaloids, which were the most abundant class. By applying Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) based on LC-ESI-MS/MS analysis, the three species were completely segregated from each other. In addition, the three Lobelia extracts were tested for their antioxidant activities using a DPPH assay and as antidiabetic agents against α-glycosidase and α-amylase enzymes. L. chinensis extract demonstrated significant antioxidant activity with an IC50 value of 1.111 mg/mL, while L. nicotianifolia showed mild suppressing activity on the α-glycosidase activity with an IC50 value of 270.8 μg/mL. A molecular simulation study was performed on the main compounds to predict their potential antidiabetic activity and pharmacokinetic properties. The molecular docking results confirmed the α-glycosidase inhibitory activity of the tested compounds, as seen in their binding mode to the key amino acid residues at the binding site compared to that of the standard drug acarbose. Furthermore, the predictive ADMET results revealed good pharmacokinetic properties of almost all of the tested compounds. The biological evaluation results demonstrated the promising activity of the tested compounds, aligned with the in silico results.
- 10 May 2023
- Published by Elsevier in Pathology - Research and Practice
- Vol. 246, 154529
The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer
- 10 May 2023
- Published by Elsevier in Pathology - Research and Practice
- Vol. 246, 154529
The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer
- Open Access
GC/MS Profiling of the Essential Oil and Lipophilic Extract of Moricandia sinaica Boiss. and Evaluation of Their Cytotoxic and Antioxidant Activities
The genus Moricandia (Brassicaceae) comprises about eight species that were used in traditional medicine. Moricandia sinaica is used to alleviate certain disorders such as syphilis and exhibits analgesic, anti-inflammatory, antipyretic, antioxidant, and antigenotoxic properties. Throughout this study, we aimed to figure out the chemical composition of lipophilic extract and essential oil obtained from M. sinaica aerial parts using GC/MS analysis, as well as their cytotoxic and antioxidant activities correlated with the major detected compounds’ molecular docking. The results revealed that both the lipophilic extract and the oil were found to be rich in aliphatic hydrocarbons, accounting for 72.00% and 79.85%, respectively. Furthermore, the lipophilic extract’s major constituents are octacosanol, γ-sitosterol, α-amyrin, β-amyrin acetate, and α-tocopherol. Contrarily, monoterpenes and sesquiterpenes accounted for the majority of the essential oil. The essential oil and the lipophilic extract of M. sinaica showed cytotoxic properties towards human liver cancer cells (HepG2) with IC50 values of 126.65 and 220.21 µg/mL, respectively. The lipophilic extract revealed antioxidant activity in the DPPH assay with an IC50 value of 2679 ± 128.13 µg/mL and in the FRAP assay, moderate antioxidant potential was expressed as 44.30 ± 3.73 µM Trolox equivalent/mg sample. The molecular docking studies revealed that ꞵ-amyrin acetate, α -tocopherol, γ-sitosterol, and n-pentacosaneachieved the best docking scores for NADPH oxidase, phosphoinositide-3 kinase, and protein kinase B. Consequently, M. sinaica essential oil and lipophilic extract can be employed as a viable management strategy for oxidative stress conditions and the formulation of improved cytotoxic treatment regimens.
Open AccessGC/MS Profiling of the Essential Oil and Lipophilic Extract of Moricandia sinaica Boiss. and Evaluation of Their Cytotoxic and Antioxidant Activities
The genus Moricandia (Brassicaceae) comprises about eight species that were used in traditional medicine. Moricandia sinaica is used to alleviate certain disorders such as syphilis and exhibits analgesic, anti-inflammatory, antipyretic, antioxidant, and antigenotoxic properties. Throughout this study, we aimed to figure out the chemical composition of lipophilic extract and essential oil obtained from M. sinaica aerial parts using GC/MS analysis, as well as their cytotoxic and antioxidant activities correlated with the major detected compounds’ molecular docking. The results revealed that both the lipophilic extract and the oil were found to be rich in aliphatic hydrocarbons, accounting for 72.00% and 79.85%, respectively. Furthermore, the lipophilic extract’s major constituents are octacosanol, γ-sitosterol, α-amyrin, β-amyrin acetate, and α-tocopherol. Contrarily, monoterpenes and sesquiterpenes accounted for the majority of the essential oil. The essential oil and the lipophilic extract of M. sinaica showed cytotoxic properties towards human liver cancer cells (HepG2) with IC50 values of 126.65 and 220.21 µg/mL, respectively. The lipophilic extract revealed antioxidant activity in the DPPH assay with an IC50 value of 2679 ± 128.13 µg/mL and in the FRAP assay, moderate antioxidant potential was expressed as 44.30 ± 3.73 µM Trolox equivalent/mg sample. The molecular docking studies revealed that ꞵ-amyrin acetate, α -tocopherol, γ-sitosterol, and n-pentacosaneachieved the best docking scores for NADPH oxidase, phosphoinositide-3 kinase, and protein kinase B. Consequently, M. sinaica essential oil and lipophilic extract can be employed as a viable management strategy for oxidative stress conditions and the formulation of improved cytotoxic treatment regimens.
- Open Access
Chemical and Biological Review of Endophytic Fungi Associated with Morus sp. (Moraceae) and In Silico Study of Their Antidiabetic Potential
The chronic nature of diabetes mellitus motivates the quest for novel agents to improve its management. The scarcity and prior uncontrolled utilization of medicinal plants have encouraged researchers to seek new sources of promising compounds. Recently, endophytes have presented as eco-friendly leading sources for bioactive metabolites. This article reviewed the endophytic fungi associated with Morus species and their isolated compounds, in addition to the biological activities tested on their extracts and chemical constituents. The relevant literature was collected from the years 2008–2022 from PubMed and Web of Science databases. Notably, no antidiabetic activity was reported for any of the Morus-associated endophytic fungal extracts or their twenty-one previously isolated compounds. This encouraged us to perform an in silico study on the previously isolated compounds to explore their possible antidiabetic potential. Furthermore, pharmacokinetic and dynamic stability studies were performed on these compounds. Upon molecular docking, Colletotrichalactone A (14) showed a promising antidiabetic activity due to the inhibition of the α-amylase local target and the human sodium-glucose cotransporter 2 (hSGT2) systemic target with safe pharmacokinetic features. These results provide an in silico interpretation of the possible anti-diabetic potential of Morus endophytic metabolites, yet further study is required.
Open AccessChemical and Biological Review of Endophytic Fungi Associated with Morus sp. (Moraceae) and In Silico Study of Their Antidiabetic Potential
The chronic nature of diabetes mellitus motivates the quest for novel agents to improve its management. The scarcity and prior uncontrolled utilization of medicinal plants have encouraged researchers to seek new sources of promising compounds. Recently, endophytes have presented as eco-friendly leading sources for bioactive metabolites. This article reviewed the endophytic fungi associated with Morus species and their isolated compounds, in addition to the biological activities tested on their extracts and chemical constituents. The relevant literature was collected from the years 2008–2022 from PubMed and Web of Science databases. Notably, no antidiabetic activity was reported for any of the Morus-associated endophytic fungal extracts or their twenty-one previously isolated compounds. This encouraged us to perform an in silico study on the previously isolated compounds to explore their possible antidiabetic potential. Furthermore, pharmacokinetic and dynamic stability studies were performed on these compounds. Upon molecular docking, Colletotrichalactone A (14) showed a promising antidiabetic activity due to the inhibition of the α-amylase local target and the human sodium-glucose cotransporter 2 (hSGT2) systemic target with safe pharmacokinetic features. These results provide an in silico interpretation of the possible anti-diabetic potential of Morus endophytic metabolites, yet further study is required.
- 24 August 2020
- Published by Wiley in Chemistry & Biodiversity
- Vol. 17 (10) , e2000496
A New Phenolic Alkaloid from Halocnemum strobilaceum Endophytes: Antimicrobial, Antioxidant and Biofilm Inhibitory Activities
Human infections caused by microbial biofilm formation represent a growing major health threat. A new alkaloid, 3‐amino‐5‐(3‐hydroxybutan‐2‐yl)‐4‐methylphenol, was isolated from the corn grit culture of the endophytic isolate Penicillium citrinum‐314 associated with Halocnemum strobilaceum, a halophyte growing in the Egyptian marshes. The new alkaloid was identified by 1D, 2D‐NMR and HR‐ESI‐MS‐MS and given the trivial name halociline. The antioxidant, antimicrobial and antibiofilm activities were recorded. Furthermore, another known compound, 1,3,6‐trihydroxy‐7‐methoxy‐9H‐xanthen‐9‐one, was obtained in smaller amounts and revealed a non‐microbicidal 100 % reduction in biofilm formation, with an MBIC value of 62.5 μg/mL (228 μM) against Pseudomonas aeruginosa (Ferm‐BAM), a FRAP value of 447.941±37.876 mM/L as well as a marked safety profile against three cancer cell lines. Through in silico molecular docking study, in the binding sites of Pseudomonas enzymes, key ligand enzyme interactions were determined to support the in vitro results.
- 24 August 2020
- Published by Wiley in Chemistry & Biodiversity
- Vol. 17 (10) , e2000496
A New Phenolic Alkaloid from Halocnemum strobilaceum Endophytes: Antimicrobial, Antioxidant and Biofilm Inhibitory Activities
Human infections caused by microbial biofilm formation represent a growing major health threat. A new alkaloid, 3‐amino‐5‐(3‐hydroxybutan‐2‐yl)‐4‐methylphenol, was isolated from the corn grit culture of the endophytic isolate Penicillium citrinum‐314 associated with Halocnemum strobilaceum, a halophyte growing in the Egyptian marshes. The new alkaloid was identified by 1D, 2D‐NMR and HR‐ESI‐MS‐MS and given the trivial name halociline. The antioxidant, antimicrobial and antibiofilm activities were recorded. Furthermore, another known compound, 1,3,6‐trihydroxy‐7‐methoxy‐9H‐xanthen‐9‐one, was obtained in smaller amounts and revealed a non‐microbicidal 100 % reduction in biofilm formation, with an MBIC value of 62.5 μg/mL (228 μM) against Pseudomonas aeruginosa (Ferm‐BAM), a FRAP value of 447.941±37.876 mM/L as well as a marked safety profile against three cancer cell lines. Through in silico molecular docking study, in the binding sites of Pseudomonas enzymes, key ligand enzyme interactions were determined to support the in vitro results.